New Drug Trials Show Promise for Lung Disease Patients, Claims Bristol Myers Squibb
NEW YORK: Bristol Myers Squibb has announced successful results from trials of its experimental drug, Admilparant, aimed at treating lung diseases.
The pharmaceutical giant reported that even low doses of the drug have shown significant…